Schedule 13G ownership disclosure
Champions Oncology Inc
Common Stock, par value $0.001 per share · CUSIP: 15870P307
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Tocqueville Asset Management L.P.
Shares: 608,915.00 · Class: 4.4%
- Taubenpost Capital L.P.
Shares: 608,915.00 · Class: 4.4%
- Taubenpost Capital LLC
Shares: 608,915.00 · Class: 4.4%
- Donald Wang
Shares: 608,915.00 · Class: 4.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-001459
- Form type
- SCHEDULE 13G/A
- Filer
- CHAMPIONS ONCOLOGY, INC.
- CIK
- CIK 771856
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership